Benjamin F. Edwards & Company, Inc. Rx Sight, Inc. Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Rx Sight, Inc. stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 81 shares of RXST stock, worth $3,649. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81
Previous 106
23.58%
Holding current value
$3,649
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RXST
# of Institutions
225Shares Held
32.3MCall Options Held
394KPut Options Held
32K-
Ra Capital Management, L.P. Boston, MA3.92MShares$176 Million2.7% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$108 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$103 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.75MShares$78.7 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.17MShares$52.7 Million0.09% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.25B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...